Probiotic pill aims to calm IBS belly troubles
NCT ID NCT06271538
First seen May 13, 2026 · Last updated Jun 14, 2026 · Updated 6 times
Summary
This study tests whether a daily supplement called Skål Pro (containing a friendly bacteria and a prebiotic fiber) can reduce belly pain, bloating, and irregular bowel movements in people with irritable bowel syndrome (IBS). About 60 adults with IBS will take either the supplement or a placebo for several weeks. Researchers will track changes in symptoms, stool consistency, quality of life, and mood to see if the supplement offers real relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATHOLOGIC PROCESSES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universiti Sains Malaysia
RECRUITINGKubang Kerian, Kelantan, 16150, Malaysia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.